Serum anti‑TSTD2 antibody as a biomarker for atherosclerosis‑induced ischemic stroke and chronic kidney disease

Autoantibodies can be used in the early diagnosis and treatment of atherosclerosis-related diseases. Using ProtoArray(®) screening of samples from patients with atherosclerosis, the present study identified thiosulfate sulfurtransferase-like domain-containing 2 (TSTD2) as a novel atherosclerosis ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubota, Masaaki, Zhang, Bo-Shi, Li, Shu-Yang, Yoshida, Yoichi, Wang, Hao, Adachi, Akihiko, Matsutani, Tomoo, Mine, Seiichiro, Machida, Toshio, Kamitsukasa, Ikuo, Wada, Takeshi, Aotsuka, Akiyo, Kitamura, Kenichiro, Takizawa, Hirotaka, Kuroda, Hideyuki, Iwadate, Yasuo, Hiwasa, Takaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829233/
https://www.ncbi.nlm.nih.gov/pubmed/36699658
http://dx.doi.org/10.3892/mi.2022.64

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829233/
https://www.ncbi.nlm.nih.gov/pubmed/36699658
http://dx.doi.org/10.3892/mi.2022.64

Ejemplares similares